Efficient in vitro amplification of a mouse-adapted scrapie prion protein

Yuichi Murayama1, Miyako Yoshioka, Takashi Yokoyama

  • 1Prion Disease Research Center, National Institute of Animal Health, 3-1-5 Kannondai, Tsukuba, Ibaraki 305-0856, Japan. ymura@affrc.go.jp

Neuroscience Letters
|December 19, 2006
PubMed

Insights

Researchers improved protein misfolding cyclic amplification (PMCA) to detect mouse scrapie prion protein (PrPSc). Adding digitonin prevents protease resistance, enabling effective amplification for prion disease research in mice.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Protein misfolding cyclic amplification (PMCA) detects scrapie prion protein (PrPSc).
  • Existing PMCA methods struggle to amplify PrPSc from species other than hamsters, particularly mice.
  • Mouse PrP(C) can develop protease resistance during incubation, hindering amplification.

Purpose of the Study:

  • Investigate the reasons for insufficient PrPSc amplification in mice.
  • Develop an improved PMCA method for amplifying mouse-adapted scrapie PrPSc.
  • Enhance prion disease research using mouse models.

Main Methods:

  • Investigated PrPSc amplification challenges in mice.
  • Developed a modified PMCA protocol.
  • Incorporated digitonin, a lipid detergent, into the reaction buffer.
  • Assessed the inhibition of protease-resistant PrPC accumulation.

Main Results:

  • Identified protease resistance of mouse PrPC as a key obstacle.
  • Demonstrated effective amplification of mouse-adapted scrapie PrPSc using the improved method.
  • Showed that digitonin prevents PrPC protease resistance during incubation.

Conclusions:

  • The study presents the first successful amplification of mouse-adapted scrapie PrPSc.
  • The enhanced PMCA technique overcomes previous limitations in mouse PrPSc detection.
  • This improved method will significantly aid prion disease research involving mouse models.

Related Concept Videos